Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 3,228.54 | 1,454.84 | 2,797.18¢ | 10.8 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,431.59 | 1,690.74 | 2,846.67¢ | 10.6 | 6.0 | +2% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
Contracting | 06-Dec-2007 | Washington Post |
United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
Currency | US Dollars |
Share Price | $ 302.41 |
Change Today | $ -2.40 |
% Change | -0.79 % |
52 Week High | $410.00 |
52 Week Low | $274.70 |
Volume | 1 |
Shares Issued | 43.56m |
Market Cap | $13,174m |
RiskGrade | 132 |
Strong Buy | 6 |
Buy | 4 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 15 |
Time | Volume / Share Price |
16:00 | 58,642 @ $302.41 |
15:59 | 170 @ $302.65 |
15:59 | 106 @ $302.65 |
15:59 | 157 @ $302.54 |
15:59 | 100 @ $302.46 |
You are here: research